Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo-controlled phase Ib/II study of JKN2306 tablets in patients after laparoscopic/thoracoscopic surgery
CTR20253536Phase 2Active
- Sponsor
- Joincare Pharmaceutical
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JKN2306 in acute pain, sponsored by Joincare Pharmaceutical. Started Sep 2025; status: active.
02
Drugs
JKN2306
03
Conditions
acute pain
Beyond the preview
Go deeper on CTR20253536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253536.